Quantcast

Latest Influenza treatment Stories

99128e9b2db0d365ba295548810b9428
2009-07-01 05:30:00

A new report shows that kidney transplant patients have a weaker response to flu vaccines than healthy individuals, especially in the first six months after receiving a transplant. Kelly A. Birdwell of Vanderbilt University Medical Center noted that transplant patients are known to be at an increased risk for respiratory viral infections, which can be particularly harmful to people with suppressed immune systems. The Centers for Disease Control and Prevention urges kidney transplant patients...

2009-06-15 11:11:02

With the H1N1 flu outbreak now elevated to pandemic level, a new article http://www.cmaj.ca/cgi/rapidpdf/cmaj.090866 in CMAJ (Canadian Medical Association Journal) reports that oseltamivir (Tamiflu®) and zanamivir (Relenza®) are relatively safe drugs for use in pregnant and breast-feeding women.Pregnant women, especially those in the third trimester, are at high risk of serious complications from the H1N1 A influenza virus.The study was conducted by...

683a9d8367283bd82d62b7dfff17822e1
2009-03-03 13:30:00

A study released Monday found that a virulent strain of influenza spreading across the United States is proving resistant to what had been the most effective anti-viral drugs, the AFP reported. Researchers found that the H1N1 subtype of influenza A viruses commonly proved resistant to the popular drug oseltamivir, according to a report in the Journal of the American Medical Association (JAMA). Swiss pharmaceutical giant Roche produced Oseltamivir, which is sold commercially in the United...

2009-03-02 10:47:00

RESEARCH TRIANGLE PARK, N.C., March 2 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) is prepared with ample supplies of the influenza antiviral medication RELENZA(R) (zanamivir) Inhalation Powder (www.RELENZA.com) to meet public health needs as the current influenza season peaks. According to newly updated influenza activity data (http://www.cdc.gov/flu/weekly/) released by the Centers for Disease Control and Prevention (CDC), the flu virus is widespread in 27 states. Relenza is a...

2009-01-19 09:00:00

SAN DIEGO, Jan. 19 /PRNewswire/ -- NexBio announces the completion of its First-In-Man clinical trial of DAS181 (Fludase(R)), an investigational drug candidate for influenza. The single-dose, escalating Phase I study completed in December 2008 was designed to assess DAS181 safety in healthy subjects. The study drug was well tolerated at all dose levels. DAS181 is a novel broad-spectrum drug candidate for prophylaxis and treatment of respiratory infections by all variations of influenza...

2008-12-19 13:48:00

RESEARCH TRIANGLE PARK, N.C., Dec. 19 /PRNewswire/ -- GlaxoSmithKline (GSK) is prepared to respond to public health needs for RELENZA(R) (zanamivir) Inhalation Powder this flu season following a Health Alert Advisory issued by the Centers for Disease Control and Prevention (CDC). RELENZA is a preferred medication in the CDC-issued interim recommendations for all circulating subtypes of influenza virus. This interim guidance is based on early and limited data from the current influenza...

2008-12-19 16:07:57

The U.S. Centers for Disease Control and Prevention said Influenza A (H1N1) is showing resistance to the drug oseltamivir (Tamiflu). The agency based in Atlanta said patients suspected of having Influenza A should instead be treated with the antiviral drug Relenza or a combination Tamiflu and rimantadine. The CDC issued the health alert advisory Friday after studying preliminary flu data from a limited number of states. The CDC said this year's flu vaccine is expected to be effective in...

2008-10-30 06:00:44

BioCryst Pharmaceuticals has announced positive results of an exploratory Phase II trial of intravenous peramivir, a neuraminidase inhibitor, in patients hospitalized for acute serious or potentially life-threatening influenza. The Phase II trial compared the efficacy and safety of five days of therapy with either 200mg intravenous (IV) peramivir per day, 400mg IV peramivir per day or 75mg oral oseltamivir twice a day, in patients who required hospitalization related to influenza. The...

22614b3f67e5edcae3e872ecd0663b6a1
2008-10-29 14:44:25

Researchers on Tuesday said a new injected influenza drug appears to reduce symptoms as well as rival drugs. In a study of 300 patients age 20 to 64, researchers found that BioCryst Inc's peramivir successfully reduced the number of days that people were sick with flu in a phase II trial for safety and efficacy. A 2007 trial failed to show the new drug worked well but longer needles apparently delivered the drug more effectively, said Dr. Bill Sheridan, chief medical officer of BioCryst....

2008-09-23 09:00:15

To: HEALTH EDITORS Contact: Terence Hurley, Roche, +1-973-562-2882, terence_j.hurley@roche.com; or Sue Preziotti, Fleishman-Hillard, +1- 212-453-2144, Sue.Preziotti@fleishman.com NUTLEY, N.J., Sept. 23 /PRNewswire/ -- Roche announced today that ample supplies of its prescription antiviral medication Tamiflu(R) (oseltamivir phosphate) will be widely available throughout the U.S. this flu season. Tamiflu, cited by the Centers for Disease Control and Prevention (CDC) as an important second...


Latest Influenza treatment Reference Libraries

69_d42a67c9e67a58fec0ffaab2b08808b2
2011-01-12 16:27:29

The common cold is a viral disease of the upper respiratory system, caused primarily by rhinoviruses and coronaviruses. Symptoms usually include a cough, sore throat, runny nose, and a fever. There is no known treatment to shorten the duration of the virus yet the cold normally dissipates after 7 to 10 days. It is the most common infectious disease in humans who on average are infected two to four times a year in adults. It can also be called a upper respiratory tract infection. Other...

More Articles (1 articles) »
Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related